ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Testing the Combination of New Anti-cancer Drug Nedisertib With Avelumab and Radiation Therapy for Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
Case Medical Research
◽
10.31525/ct1-nct04068194
◽
2019
◽
Author(s):
Keyword(s):
Radiation Therapy
◽
Solid Tumors
◽
Cancer Drug
◽
Hepatobiliary Malignancies
◽
Anti Cancer
Download Full-text
Related Documents
Cited By
References
Testing the Addition of a New Anti-cancer Drug, M3814, to Radiation Therapy for Localized Pancreatic Cancer
Case Medical Research
◽
10.31525/ct1-nct04172532
◽
2019
◽
Author(s):
Keyword(s):
Pancreatic Cancer
◽
Radiation Therapy
◽
Cancer Drug
◽
Anti Cancer
Download Full-text
Selective targeting of anti-cancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium
Cancer
◽
10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f
◽
1984
◽
Vol 54
(11)
◽
pp. 2367-2374
◽
Cited By ~ 174
Author(s):
Toshimitsu Konno
◽
Hiroshi Maeda
◽
Ken Iwai
◽
Shojiro Maki
◽
Seiki Tashiro
◽
...
Keyword(s):
Contrast Medium
◽
Image Enhancement
◽
Solid Tumors
◽
Cancer Drug
◽
Anti Cancer
◽
Selective Targeting
Download Full-text
Pharmacokinetics of panaxatrol disuccinate sodium, a novel anti-cancer drug from Panax notoginseng, in healthy volunteers and patients with advanced solid tumors
Acta Pharmacologica Sinica
◽
10.1038/aps.2010.114
◽
2010
◽
Vol 31
(11)
◽
pp. 1515-1522
◽
Cited By ~ 3
Author(s):
Zhao Yan
◽
Zhong-ling Zhu
◽
Hua-qing Wang
◽
Wei Li
◽
Ya-xian Mi
◽
...
Keyword(s):
Healthy Volunteers
◽
Solid Tumors
◽
Panax Notoginseng
◽
Cancer Drug
◽
Advanced Solid Tumors
◽
Anti Cancer
Download Full-text
Testing the Addition of an Anti-cancer Drug, M6620, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative or Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
Case Medical Research
◽
10.31525/ct1-nct04052555
◽
2019
◽
Author(s):
Keyword(s):
Breast Cancer
◽
Radiation Therapy
◽
Progesterone Receptor
◽
Triple Negative
◽
Cancer Drug
◽
Usual Treatment
◽
Anti Cancer
Download Full-text
179 POSTER Phase I study of the novel anti-cancer drug PM00104 as a 1-hour weekly infusion resting every fourth week in patients with advanced solid tumors or lymphoma
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(08)72111-6
◽
2008
◽
Vol 6
(12)
◽
pp. 57
◽
Cited By ~ 1
Author(s):
J.C. Soria
◽
R. Plummer
◽
A. Soto
◽
C. Massard
◽
H. Calvert
◽
...
Keyword(s):
Phase I
◽
Solid Tumors
◽
Phase I Study
◽
Cancer Drug
◽
Advanced Solid Tumors
◽
The Novel
◽
Weekly Infusion
◽
Anti Cancer
Download Full-text
Deactivation of anti-cancer drug letrozole to a carbinol metabolite by polymorphic cytochrome P450 2A6 in human liver microsomes
Xenobiotica
◽
10.1080/00498250903171395
◽
2009
◽
Vol 00
(00)
◽
pp. 090901052053001-8
Author(s):
K. Murai
◽
H. Yamazaki
◽
K. Nakagawa
◽
R. Kawai
◽
T. Kamataki
Keyword(s):
Cytochrome P450
◽
Human Liver
◽
Liver Microsomes
◽
Human Liver Microsomes
◽
Cancer Drug
◽
Anti Cancer
◽
Cytochrome P450 2A6
Download Full-text
Anti-Cancer Drug Prevents, Reverses Cardiovascular Damage In Mouse Model of Premature Aging Disorder
PsycEXTRA Dataset
◽
10.1037/e532862012-001
◽
2008
◽
Keyword(s):
Mouse Model
◽
Premature Aging
◽
Cancer Drug
◽
Cardiovascular Damage
◽
Anti Cancer
Download Full-text
Psychogenic Mass Syndrome in Anti-Cancer Drug Exposure
PsycEXTRA Dataset
◽
10.1037/e572992012-432
◽
2010
◽
Author(s):
N. Magnavita
◽
I. lavicoli
◽
V. Leso
◽
A. Bergamaschi
Keyword(s):
Drug Exposure
◽
Cancer Drug
◽
Anti Cancer
Download Full-text
The effective role of hydroxyapatite-based composites in anti-cancer drug delivery systems
Critical Reviews in Therapeutic Drug Carrier Systems
◽
10.1615/critrevtherdrugcarriersyst.v33.i1.10
◽
2016
◽
Vol 33
(1)
◽
Author(s):
Samaneh Saber-Samandari
Keyword(s):
Drug Delivery
◽
Drug Delivery Systems
◽
Delivery Systems
◽
Cancer Drug
◽
Anti Cancer
◽
Effective Role
◽
Cancer Drug Delivery
Download Full-text
Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
Case Medical Research
◽
10.31525/ct1-nct04164082
◽
2019
◽
Author(s):
Keyword(s):
Bladder Cancer
◽
Intravesical Chemotherapy
◽
Invasive Bladder Cancer
◽
Cancer Drug
◽
Chemotherapy Treatment
◽
Muscle Invasive Bladder Cancer
◽
Anti Cancer
◽
Muscle Invasive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close